Advertisement

Topics

STAT Plus: Alkermes’s depression drug is back on track after an FDA ‘misunderstanding’

09:17 EDT 16 Apr 2018 | STAT

Just two weeks after a rare rebuke from the FDA derailed Alkermes's treatment for serious depression, the company has convinced the agency to change its mind and give the drug

Original Article: STAT Plus: Alkermes’s depression drug is back on track after an FDA ‘misunderstanding’

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Alkermes’s depression drug is back on track after an FDA ‘misunderstanding’"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...